Literature DB >> 12540348

An economic analysis of external hip protector use in ambulatory nursing facility residents.

Cathleen S Colón-Emeric1, Santanu K Datta, David B Matchar.   

Abstract

OBJECTIVE: to evaluate the economic impact of external hip protector use in nursing facilities.
DESIGN: cost-effectiveness and cost-utility analyses. MEASUREMENTS: event probabilities, intervention effectiveness, treatment costs, and utility of hip fracture state were determined from peer-reviewed medical literature and public use data.
METHODS: a societal perspective with an 18-month time horizon was used. A decision tree model was constructed. Expected cost, effectiveness, and incremental cost-effectiveness ratio were calculated. One and two-way sensitivity analyses and threshold analyses were performed.
RESULTS: the strategy of using external hip protectors saves approximately US$300 per subject and adds 0.01 quality adjusted life year over 18 months. The model remains dominant over the entire range of input values for all variables except the cost of hip protectors. At the maximum estimated cost of US$695/subject/18 months, the incremental cost-effectiveness ratio was $30,600/quality adjusted life year. The strategy of using hip protectors was cost saving or cost neutral if the cost of hip protector strategy is <or=US$397/subject/18 months.
CONCLUSIONS: using external hip protectors in nursing facilities is cost saving or economically attractive over a wide range of cost and utility assumptions.

Entities:  

Mesh:

Year:  2003        PMID: 12540348     DOI: 10.1093/ageing/32.1.47

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  16 in total

Review 1.  Osteoporotic fractures in older adults.

Authors:  Cathleen S Colón-Emeric; Kenneth G Saag
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-08       Impact factor: 4.098

Review 2.  Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature.

Authors:  Rachael L Fleurence; Cynthia P Iglesias; David J Torgerson
Journal:  Osteoporos Int       Date:  2005-06-25       Impact factor: 4.507

3.  Subsequent contralateral hip fractures: can at-risk patients be identified? An observational study of 5,102 patients.

Authors:  Jiří Skála-Rosenbaum; Valér Džupa; Radek Bartoška; Daniel Říha; Petr Waldauf; Václav Báča
Journal:  Int Orthop       Date:  2015-01-08       Impact factor: 3.075

4.  Quantity and Quality of Economic Evaluations in U.S. Nursing Research, 1997-2015: A Systematic Review.

Authors:  Wendy A Cook; Megan L Morrison; Linda H Eaton; Brian R Theodore; Ardith Z Doorenbos
Journal:  Nurs Res       Date:  2017 Jan/Feb       Impact factor: 2.381

5.  Cost-effectiveness of hip protectors in frail institutionalized elderly.

Authors:  Natasja M van Schoor; Martine C de Bruyne; Nicole van der Roer; Els Lommerse; Maurits W van Tulder; Lex M Bouter; Paul Lips
Journal:  Osteoporos Int       Date:  2004-04-22       Impact factor: 4.507

6.  Systematic review of unintentional injury prevention economic evaluations 2010-2019 and comparison to 1998-2009.

Authors:  Mallika Mahalingam; Cora Peterson; Gwen Bergen
Journal:  Accid Anal Prev       Date:  2020-09-09

Review 7.  [The role of hip protectors in the prevention of hip fractures in older people].

Authors:  Lukas A Holzer; Gerold Holzer
Journal:  Wien Med Wochenschr       Date:  2007

8.  External hip protectors are effective for the elderly with higher-than-average risk factors for hip fractures.

Authors:  T Koike; Y Orito; H Toyoda; M Tada; R Sugama; M Hoshino; Y Nakao; S Kobayashi; K Kondo; Y Hirota; K Takaoka
Journal:  Osteoporos Int       Date:  2009-01-10       Impact factor: 4.507

9.  Cost Effectiveness of Falls and Injury Prevention Strategies for Older Adults Living in Residential Aged Care Facilities.

Authors:  Jody L Church; Marion R Haas; Stephen Goodall
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

10.  Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II).

Authors:  I D Cameron; S Robinovitch; S Birge; P Kannus; K Khan; J Lauritzen; J Howland; S Evans; J Minns; A Laing; P Cripton; S Derler; D Plant; D P Kiel
Journal:  Osteoporos Int       Date:  2010-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.